Madueke-Laveaux OS

No ORCID on file · 5 papers in corpus
2026
Cells ·doi:10.3390/cells15161469

Uterine fibroids, the most common tumors in reproductive-age women, remain without a defined precursor tissue state. Unlike cervical dysplasia preceding cervical cancer, or colonic polyps preceding colorectal malignancy, no equivalent "at-r…

2025
International journal of women's health ·doi:10.2147/ijwh.s523846

BackgroundLimited evidence is available regarding preferences of women with uterine fibroids (UF) and treating healthcare providers (HCPs) regarding treatment attributes; this evidence could contribute to patient-centered shared decision-ma…

2024
Journal of medical imaging (Bellingham, Wash.) ·doi:10.1117/1.jmi.11.5.054501

SignificanceUterine fibroids (UFs) can pose a serious health risk to women. UFs are benign tumors that vary in clinical presentation from asymptomatic to causing debilitating symptoms. UF management is limited by our inability to predict UF…

2023
F&S reports ·doi:10.1016/j.xfre.2022.11.008

Treatment of heavy menstrual bleeding associated with uterine fibroids (UF) is evolving. Historically, treatment options were limited to predominantly invasive surgery; today, conservative and novel oral medical treatments are widely availa…

article 2023
Journal of endometriosis and uterine disorders ·doi:10.1016/j.jeud.2023.100018

• Uterine fibroids are the most common benign tumor to women of reproductive age with no clear pathomechanism. • Current medical therapies are designed to blunt the stimulatory effects of gonadal steroid hormones on uterine fibroids growth.…